Smith & Nephew plc (NYSE:SNN) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Smith & Nephew plc (NYSE:SNN) have been assigned a consensus rating of “Hold” from the six brokerages that are currently covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation. The average 12 month price target among brokerages that have covered the stock in the last year is $28.00.

A number of research firms have recently issued reports on SNN. Canaccord Genuity Group lifted their price objective on shares of Smith & Nephew from $27.00 to $28.00 and gave the stock a “hold” rating in a report on Thursday, May 1st. UBS Group downgraded shares of Smith & Nephew from a “buy” rating to a “neutral” rating in a report on Wednesday, March 12th. HSBC downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, April 25th. Wall Street Zen raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, February 26th. Finally, Hsbc Global Res downgraded shares of Smith & Nephew from a “strong-buy” rating to a “hold” rating in a research note on Friday, April 25th.

Hedge Funds Weigh In On Smith & Nephew

Hedge funds and other institutional investors have recently modified their holdings of the company. Hexagon Capital Partners LLC raised its stake in shares of Smith & Nephew by 63.3% during the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 406 shares during the last quarter. Richards Merrill & Peterson Inc. raised its stake in shares of Smith & Nephew by 500.0% during the first quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 1,000 shares during the last quarter. Principal Securities Inc. raised its stake in shares of Smith & Nephew by 87.6% during the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 691 shares during the last quarter. National Bank of Canada FI raised its stake in shares of Smith & Nephew by 36.5% during the fourth quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider’s stock valued at $41,000 after acquiring an additional 446 shares during the last quarter. Finally, Bessemer Group Inc. raised its stake in shares of Smith & Nephew by 3,471.4% during the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider’s stock valued at $49,000 after acquiring an additional 1,701 shares during the last quarter. 25.64% of the stock is owned by institutional investors.

Smith & Nephew Stock Performance

NYSE SNN opened at $29.33 on Friday. Smith & Nephew has a 52-week low of $23.69 and a 52-week high of $31.72. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The company has a market capitalization of $12.84 billion, a P/E ratio of 13.58, a P/E/G ratio of 1.26 and a beta of 0.68. The company has a fifty day moving average of $27.95 and a 200-day moving average of $26.84.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.